Uta Wegewitz

1.9k total citations
38 papers, 1.3k citations indexed

About

Uta Wegewitz is a scholar working on General Health Professions, Statistics, Probability and Uncertainty and Clinical Psychology. According to data from OpenAlex, Uta Wegewitz has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in General Health Professions, 9 papers in Statistics, Probability and Uncertainty and 8 papers in Clinical Psychology. Recurrent topics in Uta Wegewitz's work include Workplace Health and Well-being (17 papers), Employment and Welfare Studies (12 papers) and Meta-analysis and systematic reviews (9 papers). Uta Wegewitz is often cited by papers focused on Workplace Health and Well-being (17 papers), Employment and Welfare Studies (12 papers) and Meta-analysis and systematic reviews (9 papers). Uta Wegewitz collaborates with scholars based in Germany, United States and Netherlands. Uta Wegewitz's co-authors include Andreas Pfeiffer, Joachim Spranger, Matthias Möhlig, Dawid Pieper, Anja Jacobs, Alba Fishta, Beate Weikert, Michael Ristow, Thomas Bobbert and Knut Mai and has published in prestigious journals such as Diabetes, Cochrane Database of Systematic Reviews and Journal of Clinical Epidemiology.

In The Last Decade

Uta Wegewitz

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uta Wegewitz Germany 16 426 274 257 219 190 38 1.3k
Danielle H. Morris United Kingdom 18 168 0.4× 116 0.4× 181 0.7× 82 0.4× 79 0.4× 26 1.4k
Konstantinos I. Bougioukas Greece 13 110 0.3× 118 0.4× 138 0.5× 107 0.5× 142 0.7× 42 1.2k
Laurie Hoyt Huffman United States 10 150 0.4× 134 0.5× 243 0.9× 48 0.2× 42 0.2× 15 2.0k
Sarah Cockayne United Kingdom 20 163 0.4× 125 0.5× 125 0.5× 94 0.4× 91 0.5× 56 1.5k
Dang Wei China 14 84 0.2× 86 0.3× 70 0.3× 90 0.4× 161 0.8× 48 1.0k
Deborah R. Zucker United States 16 98 0.2× 116 0.4× 71 0.3× 202 0.9× 129 0.7× 29 1.1k
Gregory Traversy Canada 10 199 0.5× 123 0.4× 135 0.5× 67 0.3× 32 0.2× 14 919
Hans de Beer Netherlands 8 102 0.2× 112 0.4× 110 0.4× 76 0.3× 71 0.4× 16 1.0k
Eva Madrid Chile 16 59 0.1× 79 0.3× 132 0.5× 90 0.4× 39 0.2× 85 1.2k
Caitlin Daly United Kingdom 14 120 0.3× 60 0.2× 204 0.8× 30 0.1× 161 0.8× 30 1.0k

Countries citing papers authored by Uta Wegewitz

Since Specialization
Citations

This map shows the geographic impact of Uta Wegewitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Wegewitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Wegewitz more than expected).

Fields of papers citing papers by Uta Wegewitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uta Wegewitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Wegewitz. The network helps show where Uta Wegewitz may publish in the future.

Co-authorship network of co-authors of Uta Wegewitz

This figure shows the co-authorship network connecting the top 25 collaborators of Uta Wegewitz. A scholar is included among the top collaborators of Uta Wegewitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uta Wegewitz. Uta Wegewitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Erim, Yeşim, Christoph Kröger, Volker Köllner, et al.. (2024). Psychotherapeutische Sprechstunde am Arbeitsplatz: Zusammenhänge zwischen Unternehmensgröße und psychosomatischer Gesundheit. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 67(7). 772–782.
3.
Schröder, Ute, Uta Wegewitz, Peter Angerer, et al.. (2024). Implementierung einer psychotherapeutischen Sprechstunde am Arbeitsplatz (PT-A): Erwartungen, Bekanntmachung und Nutzung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 67(7). 796–805.
4.
Santis, Karina Karolina De, Dawid Pieper, Robert C. Lorenz, et al.. (2023). User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary. BMC Medical Research Methodology. 23(1). 63–63. 13 indexed citations
5.
Puljak, Livia, Małgorzata M Bała, Tim Mathes, et al.. (2023). AMSTAR 2 is only partially applicable to systematic reviews of non-intervention studies: a meta-research study. Journal of Clinical Epidemiology. 163. 11–20. 10 indexed citations
7.
Pieper, Dawid, Barbara Buchberger, Roland Brian Büchter, et al.. (2023). Was wird unter einer Public-Health-Intervention verstanden? Ergebnisse eines Delphi-Prozesses im deutschsprachigen Raum. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 182-183. 89–97.
8.
Schubert, Melanie, et al.. (2022). Stigmatisierungserfahrungen bei beruflich Pflegenden im Kontext von Covid-19 – eine Qualitative Studie. Das Gesundheitswesen. 84(4). 310–318. 1 indexed citations
9.
Wegewitz, Uta, et al.. (2021). Employees Receiving Inpatient Treatment for Common Mental Disorders in Germany: Factors Associated with Time to First and Full Return to Work. Journal of Occupational Rehabilitation. 32(1). 114–127. 6 indexed citations
10.
Matthias, Katja, Olesja Rissling, Dawid Pieper, et al.. (2020). The methodological quality of systematic reviews on the treatment of adult major depression needs improvement according to AMSTAR 2: A cross-sectional study. Heliyon. 6(9). e04776–e04776. 47 indexed citations
11.
Lorenz, Robert C., Katja Matthias, Dawid Pieper, et al.. (2019). A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. Journal of Clinical Epidemiology. 114. 133–140. 127 indexed citations
13.
Pieper, Dawid, et al.. (2018). How is AMSTAR applied by authors – a call for better reporting. BMC Medical Research Methodology. 18(1). 56–56. 53 indexed citations
14.
Fishta, Alba, et al.. (2017). Determinants of Sickness Absence and Return to Work Among Employees with Common Mental Disorders: A Scoping Review. Journal of Occupational Rehabilitation. 28(3). 393–417. 141 indexed citations
15.
Pieper, Dawid, Anja Jacobs, Beate Weikert, Alba Fishta, & Uta Wegewitz. (2017). Inter-rater reliability of AMSTAR is dependent on the pair of reviewers. BMC Medical Research Methodology. 17(1). 98–98. 22 indexed citations
16.
Bühn, Stefanie, Tim Mathes, Uta Wegewitz, et al.. (2017). The risk of bias in systematic reviews tool showed fair reliability and good construct validity. Journal of Clinical Epidemiology. 91. 121–128. 46 indexed citations
17.
Bobbert, Thomas, Uta Wegewitz, Lars Brechtel, et al.. (2007). Adiponectin Oligomers in Human Serum during Acute and Chronic Exercise: Relation to Lipid Metabolism and Insulin Sensitivity. International Journal of Sports Medicine. 28(1). 1–8. 62 indexed citations
18.
Glei, Michael, Stefanie Klenow, Julia Sauer, et al.. (2005). Hemoglobin and hemin induce DNA damage in human colon tumor cells HT29 clone 19A and in primary human colonocytes. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 594(1-2). 162–171. 74 indexed citations
19.
Wegewitz, Uta, Isabel Göhring, & Joachim Spranger. (2005). Novel Approaches in the Treatment of Angiogenic Eye Disease. Current Pharmaceutical Design. 11(18). 2311–2330. 15 indexed citations
20.
Möhlig, Matthias, Uta Wegewitz, Martin Osterhoff, et al.. (2002). Insulin Decreases Human Adiponectin Plasma Levels. Hormone and Metabolic Research. 34(11/12). 655–658. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026